Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.63B |
| 2 |
Meta Platforms (Facebook)
META
|
+$1.14B |
| 3 |
Oracle
ORCL
|
+$1.04B |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$859M |
| 5 |
S&P Global
SPGI
|
+$832M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$1.17B |
| 2 |
Trade Desk
TTD
|
+$1B |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$895M |
| 4 |
Constellation Brands
STZ
|
+$861M |
| 5 |
Carvana
CVNA
|
+$851M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.43% |
| 2 | Financials | 12.09% |
| 3 | Consumer Discretionary | 8.79% |
| 4 | Healthcare | 8.71% |
| 5 | Communication Services | 6.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2826
State Street SPDR Portfolio Corporate Bond ETF
SPBO
$2.09B
| $17.4M | ﹤0.01% |
600,008
+61,787
| +11% | +$1.78M |
|
2827
Materion
MTRN
$5.85B
| $17.4M | ﹤0.01% |
213,457
-1,364
| -0.6% | -$129K |
|
2828
International Bancshares
IBOC
$4.48B
| $17.4M | ﹤0.01% |
276,003
-91,990
| -25% | -$5.95M |
|
2829
Synaptics
SYNA
$4.18B
| $17.4M | ﹤0.01% |
272,870
-150,963
| -36% | -$10.9M |
|
2830
VEON
VEON
$3.92B
| $17.4M | ﹤0.01% |
398,411
+116,923
| +42% | +$5.2M |
|
2831
TRI-Continental Corp
TY
$1.91B
| $17.4M | ﹤0.01% |
566,027
-5,075
| -0.9% | -$162K |
|
|
BWG
2832
BrandywineGLOBAL Global Income Opportunities Fund
BWG
$130M
| $17.3M | ﹤0.01% |
2,076,656
+154,796
| +8% | +$1.29M |
|
2833
CONMED
CNMD
$1.48B
| $17.3M | ﹤0.01% |
286,707
-28,405
| -9% | -$1.83M |
|
2834
Keros Therapeutics
KROS
$211M
| $17.3M | ﹤0.01% |
1,697,557
+1,040,756
| +158% | +$12.1M |
|
2835
Banner Corp
BANR
$2.47B
| $17.3M | ﹤0.01% |
271,182
-40,799
| -13% | -$2.75M |
|
2836
Argan
AGX
$8.11B
| $17.3M | ﹤0.01% |
131,783
+16,534
| +14% | +$2.31M |
|
|
DNB
2837
DELISTED
Dun & Bradstreet
DNB
| $17.3M | ﹤0.01% |
1,932,365
+808,649
| +72% | +$8.28M |
|
2838
FlexShares International Quality Dividend Index Fund
IQDF
$1.17B
| $17.3M | ﹤0.01% |
692,698
+25,539
| +4% | +$626K |
|
2839
Werner Enterprises
WERN
$2.18B
| $17.3M | ﹤0.01% |
589,288
-101,986
| -15% | -$3.43M |
|
2840
Crinetics Pharmaceuticals
CRNX
$8.95B
| $17.3M | ﹤0.01% |
514,684
+9,644
| +2% | +$360K |
|
2841
BioCryst Pharmaceuticals
BCRX
$2.64B
| $17.2M | ﹤0.01% |
2,297,674
+631,942
| +38% | +$5.1M |
|
2842
iShares MSCI Intl Value Factor ETF
IVLU
$4.53B
| $17.2M | ﹤0.01% |
567,268
+63,294
| +13% | +$1.85M |
|
2843
JPMorgan Diversified Return International Equity ETF
JPIN
$374M
| $17.2M | ﹤0.01% |
300,262
-8,848
| -3% | -$497K |
|
|
BBNX
2844
Beta Bionics
BBNX
$791M
| $17.2M | ﹤0.01% |
+1,401,653
| New | +$26.1M |
|
2845
First Trust Nasdaq Oil & Gas ETF
FTXN
$163M
| $17.2M | ﹤0.01% |
566,389
-71,092
| -11% | -$2.12M |
|
2846
Nuveen Dynamic Municipal Opportunities Fund
NDMO
$603M
| $17.1M | ﹤0.01% |
1,670,328
-6,596
| -0.4% | -$68.4K |
|
|
UNIT
2847
Uniti Group
UNIT
$2.25B
| $17.1M | ﹤0.01% |
3,399,841
-197,457
| -5% | -$1.07M |
|
2848
Veeco
VECO
$3.06B
| $17.1M | ﹤0.01% |
852,767
+121,418
| +17% | +$2.91M |
|
2849
NCR Voyix
VYX
$1.11B
| $17.1M | ﹤0.01% |
1,755,387
-428,955
| -20% | -$5.04M |
|
2850
Andersons Inc
ANDE
$2.18B
| $17.1M | ﹤0.01% |
397,316
+10,331
| +3% | +$439K |
|
Similar funds
Morgan Stanley's Q1 2025 Portfolio in Review
As of Q1 2025, Morgan Stanley held 8,359 positions worth $1.4T, down 2% from $1.43T the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Morgan Stanley's Q1 2025 filing shows 410 new, 3,433 increased, 3,308 reduced and 270 closed positions. Its largest new stake was Sandisk: 1,632,771 shares worth $77.7M. The largest sale was Intel, an estimated $1.17B.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 23% a quarter earlier, followed by Financials and Consumer Discretionary.
- Morgan Stanley's largest Q1 2025 buy was Sandisk: 1,632,771 shares worth $77.7M.
- Morgan Stanley added most to Invesco QQQ Trust in Q1 2025, an estimated $1.63B increase.
- Morgan Stanley's biggest Q1 2025 reduction was Intel, cutting an estimated $1.17B.
- Morgan Stanley fully exited Inari Medical, Inc. Common Stock in Q1 2025, selling an estimated $110M.
- Morgan Stanley's ten largest holdings make up 20% of its $1.4T portfolio in Q1 2025.
- Morgan Stanley opened 410 new positions and closed 270 in Q1 2025.
- Morgan Stanley's portfolio value fell 2% quarter-over-quarter to $1.4T.
Based on Morgan Stanley's 13F filing for Q1 2025, filed 15 May 2025.